Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IodAID is a marine-derived nutraceutical ingredient developed by Abyss Ingredients, sourced from the upcycling of North Atlantic brown seaweeds, specifically *Ascophyllum nodosum* and *Fucus vesiculosus*. It is naturally rich in iodine, minerals, fucoidan, and marine polyphenols. While its primary marketed applications include supporting thyroid function, hormonal health, and cognitive performance due to its high iodine content, it also contains bioactive polyphenols that support glycemic health by inhibiting α-amylase and α-glucosidase enzymes. The ingredient is produced via a water-based manufacturing process that concentrates essential minerals while reducing sodium levels, and it is available in both soluble powder and liquid forms for use in oral dietary supplements.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on IodAID.